Life Sciences

Leggat McCall Properties and DLJ Real Estate Capital Partners opened a 370,000-rsf life sciences building at Boynton Yards in Somerville in November of 2024. Strategically sited less than a mile from Kendall Square, 808 Windsor was designed by ARC/Architectural Resources Cambridge as a catalyst for biomedical and pharmaceutical innovation. JLL Capital Markets arranged $246 million in construction financing for the project with capital partner Deutsche Finance America.

The vision of biomedical research as a collective effort is resoundingly clear in the $237.5 million Pelotonia Research Center, the first building to be completed in the 350-plus-acre Carmenton district on the campus of The Ohio State University (Ohio State) in Columbus. Opened in May 2023, the center integrates almost 100,000 sf of wet labs, 25,000 sf of computational labs, and 20,000 sf of core labs in a single facility designed to host interdisciplinary collaborations and public-private initiatives that focus on solving some of the most critical health challenges. With life science as the backbone of the research endeavor, current projects range from modeling cancer progressions to 3D printing of patient-specific anatomic models. 

The Sam and Ann Barshop Institute for Longevity and Aging Studies at the University of Texas Health in San Antonio illustrates the pivotal role location plays in enhancing the success of an internationally recognized research program. The Institute previously occupied two buildings at a research park 23 miles from the university’s main campus. University administrators wanted to collocate all research on the same campus to promote multidisciplinary collaboration and interaction, with proximity to all clinical research activities, and to promote efficiency and the shared use of resources. 

Attovia Therapeutics is relocating to 26,000 sf at Brittan West, a recently completed life sciences center in San Carlos, Calif. JLL acted as leasing agent for the facility, which will enable the company to expand its research activities and accelerate the creation of novel biotherapeutics for immune-mediated diseases. Access to world-class amenities will enhance collaboration and optimize the employee experience.